Is Glenmark Pharmaceuticals Limited stock a buy or sell right now?

Based on current indicators, Glenmark Pharmaceuticals Limited shows a Sell signal, with bearish momentum and trend strength favoring downside.

What is Glenmark Pharmaceuticals Limited’s RSI?

RSI is 45.41, showing balanced momentum within the normal range.

What does MACD indicate for GLENMARK.NS?

MACD at -28.89 shows bearish pressure, with downside momentum building.

What are Glenmark Pharmaceuticals Limited’s key support and resistance levels?

Support sits around $2068.83, while resistance is near $2326.71.

Glenmark Pharmaceuticals Limited (GLENMARK.NS) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Glenmark Pharmaceuticals Limited.

GLENMARK.NS●NSE

HealthcareDrug Manufacturers - Specialty & Generic

₹2179.40

₹12.50(0.57%)

Indian Market is Open · 09:22

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

GLENMARK.NS Technical Analysis Summary

Glenmark Pharmaceuticals Limited stock currently trades in a neutral range, with no clear dominance from buyers or sellers.

Overall Sentiment:Neutral

Momentum:Neutral to Bearish (RSI: 45.41)

Trend Strength:Moderate (ADX: 24.61)

Volatility:Medium (ATR: 66.85)

Support/Resistance:$2068.83 – $2326.71 (Bollinger Bands)

This mix signals that Glenmark Pharmaceuticals Limited is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 45.41

Bearish

Below midpoint indicates downward pressure.

Stochastic %K: 62.02

Bullish

Buying momentum building without extremes.

Williams %R: -48.25

Neutral

Balanced market without strong signals.

Rate of Change (ROC): 0.25

Neutral

Price change is minimal.

Takeaway:Glenmark Pharmaceuticals Limited shows neutral momentum, with indicators pointing to indecision.

Trend & Volatility

MACD: -28.89

Bearish

Bearish, trend momentum is strengthening to the downside.

ADX: 24.61

Moderate

Moderate trend, direction gaining strength.

ATR (14): 66.85

Rising

Rising volatility, market activity increasing.

CCI (14): 85.92

Bullish

Bullish, momentum building upward.

Takeaway:Glenmark Pharmaceuticals Limited shows a firm trend supported by momentum, though one signal suggests caution.

Support & Resistance indicators

Bollinger Bands

Upper Band

$2326.71

Middle Band (SMA 20)

$2197.77

Lower Band

$2068.83

Current Position

Within Bands

Takeaway:Glenmark Pharmaceuticals Limited trades closer to support, showing weaker momentum within bands.

Keltner Channels

Upper Channel

$2335.17

Middle Line (EMA 20)

$2201.47

Lower Channel

$2067.78

Squeeze Status

Squeeze On

Takeaway:Glenmark Pharmaceuticals Limited trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis

On-Balance Volume-3.49M

Money Flow Index49.23Neutral, balanced money flows with no clear signal.

Relative Vigor Index47.57Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:GLENMARK.NS shows neutral money flow, with no clear directional pressure.

Technical Trading Signals Summary

Based on the current technical analysis of Glenmark Pharmaceuticals Limited, here are the key trading signals and recommendations:

Bullish Signals

ADX above 20 → strong underlying trend.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Glenmark Pharmaceuticals Limited shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.